Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 176-183

  Li, Xiao ^a   Wu, Lingyun ^a   Ying, Shaoxu ^a   Chang, Chunkang ^a   Pu, Quan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Clone; Dysplasia; Myelodysplastic syndromes

Indexed keywords

ARTICLE; CHROMOSOME; CHROMOSOME ABERRATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LEUKOCYTE DISORDER; MAJOR CLINICAL STUDY; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COHORT STUDIES; ERYTHROBLASTS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MEGAKARYOCYTES; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PELGER-HUET ANOMALY;

EID: 42049102826     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0038-y     Document Type: Article

References (26)

1. Baurmann H, Schwarz TF, Oertel J. Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Ann Hematol. 1992;l64:43-5.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The French-American-British (FAB) co-operative group, proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-99.
3. Bowen D. What is ineffective erythropoiesis in myelodysplastic syndromes? Leuk Lymphoma. 1995;18:243-7.
4. Cantu Rajnoldi A, Fenu S, Kerndrup G, van Wering ER, Niemeyer CM, Baumann I; European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 2005;84:429-33.
5. Fontenay-Roupie M, Bouscary D, Guesnu M, Picard F, Melle J, Lacombe C, Gisselbrecht S, Mayeux P, Dreyfus F. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction. Br J Haematol. 1999;106:464-73.
6. Gladwin AM, Martin JF. The control of megakaryocyte ploidy and platelet production: biology and pathology. Int J Cell Cloning. 1990;8:291-8.
7. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol. 1992;19:4-13.
8. Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002;100:1493-5.
9. Hast R, Eriksson M, Widell S, et al. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leuk Res. 1999;23:579-84.
10. Hast R, Nilsson I, Widell S, Ost A. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. Leuk Res. 1989;13:173-8.
11. Hast R, Widell S. Dysplastic peripheral blood polymorphs link acute myeloblastic leukemia in elderly to the myelodysplastic syndromes. Eur J Haematol. 1992;48:163-7.
12. Hellstroröm-Lindberg E, Kanthor-Lewensohn L, Öst Å. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res. 1997;21:415-25.
13. Irving JA, Mattman A, Lockitch G, Farrell K, Wadsworth LD. Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ. 2003;169:129-31.
14. Kobayashi Y, Ozawa M, Maruo N, Kondo M. Megakaryocyte ploidy in patients with myelodysplastic syndrome-by microcytofluorometry with DAPI staining after removal of Wright-Giemsa staining. Rinsho Ketsueki. 1989;30:1915-22.
15. Levine RF. Isolation and characterization of normal human megakaryocytes. Br J Haematol. 1980;45:487-97.
16. Li X, Bryant CE, Deeg HJ. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol. 2004;80:140-5.
17. Li X, Pu Q. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leuk Lymphoma. 2005;46:387-91.
18. Multani AS, Hopwood VL, Pathak S. A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res. 1996;16:3435-7.
19. Ohshima K, Kikuchi M, Takeshita M. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. J Pathol. 1995;177:181-9.
20. Pagliuca A, Mufti GJ. Clinicomorphological features of myelodysplastic syndromes. In: Mufti GJ, Galton DAG, editors. The myelodysplastic syndromes. Edinburgh: Churchill Livingstone; 1992.
21. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Harvey Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268-76.
22. Rosati S, Anastasi J, Vardiman J. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol. 1996;l33:111-26.
23. Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, Hirokawa K, Kitagawa M. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk Res. 2003;27:583-91.
24. Van Lom K, Houtsmuller AB, van Putten WL, Slater RM, Lowenberg B. Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy. Genes Chromosomes Cancer. 1999;25:332-8.
25. Westhoff DD, Samaha RJ, Barnes AJ. Arsenic intoxication as a cause of megaloblastic anemia. Blood. 1975;45:241-6.
26. Widell S, Hast R. Balloon-like platelets in myelodysplastic syndromes-a feature of dysmegakaryopoiesis? Leuk Res. 1987;11:747-52.